outcomeCategory,disease,model,comparison,database,nTNF,nComparator,HazardRatio,RobustWaldLower,RobustWaldUpper,indValidHR,indSigHR
Cancer,Hematologic Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,727,1750,2.9510412E-6,1.577214E-6,5.5215362E-6,0,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3373,6233,0.2214648558,0.0783029691,0.6263706589,1,1
Cancer,Hematologic Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,559,8014,0.5558791306,0.2276509082,1.3573484519,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,727,1750,8.0571968E-7,3.732566E-7,1.7392437E-6,0,0
Cancer,Hematologic Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3373,6233,0.2656553428,0.0876728114,0.8049560638,1,1
Cancer,Hematologic Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,559,8014,0.4349570224,0.0965032873,1.9604265989,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,727,1750,7.621524E-7,3.5394557E-7,1.6411458E-6,0,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3373,6233,0.261279167,0.0863343729,0.7907256498,1,1
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,559,8014,0.4298092666,0.0947041826,1.9506636411,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,727,1750,8.1463555E-7,3.8480785E-7,1.7245778E-6,0,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3373,6233,0.2611413133,0.0863733712,0.7895348364,1,1
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,559,8014,0.3983843515,0.0967832471,1.639850866,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,727,1750,7.9337758E-7,3.6795612E-7,1.7106605E-6,0,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3373,6233,0.2660333904,0.0877941812,0.8061327513,1,1
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,559,8014,0.4336717093,0.0963562742,1.9518308801,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,727,1750,7.4966691E-7,3.5413758E-7,1.5869552E-6,0,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3373,6233,0.2563457101,0.0849310486,0.773723205,1,1
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,559,8014,0.3953342611,0.0937880648,1.6664079626,1,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,727,1750,2.6039688E-7,1.1478794E-7,5.907113E-7,0,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3373,6233,0.2580069294,0.0863840455,0.7706003492,1,1
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,559,8014,0.4353364334,0.0959901085,1.9743472868,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,0.905533837,0.4214315807,1.9457287197,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,0.9783824725,0.6019253103,1.59028412,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,0.7360214229,0.4999484024,1.0835668887,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,1.4341662005,0.3121624621,6.588981509,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,1.1215415069,0.6488172314,1.9386898047,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,0.7606756427,0.4561305174,1.2685567207,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,1.4170789681,0.3054724681,6.5737930964,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,1.1169690167,0.6460710774,1.9310875039,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,0.7639379808,0.4581767108,1.2737470606,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,1.4464630261,0.3180229452,6.5789444352,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,1.0937067963,0.6330689481,1.8895170264,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,0.6858894293,0.4177333551,1.126183254,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,1.4341687564,0.3121632402,6.5889885697,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,1.12153146,0.6488224418,1.9386395023,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,0.7602866744,0.461050386,1.2537367821,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,1.4157330921,0.3109042765,6.4466793794,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,1.0859727769,0.628353068,1.8768697606,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,0.686544734,0.4206972291,1.1203869177,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,1.3941658558,0.3223303078,6.0301448122,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,1.0899968942,0.6294909629,1.8873872691,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,0.7520396533,0.4475501578,1.2636877237,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,718,1739,0.2337755667,0.1130793109,0.4832980957,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3345,6176,0.5052438951,0.366058849,0.6973506971,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,516,7777,0.5759783284,0.4164891897,0.7965417662,1,1
Cancer,Solid Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,718,1739,0.192579827,0.0614998419,0.6030420344,1,1
Cancer,Solid Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3345,6176,0.6659799848,0.4501927032,0.9851988648,1,1
Cancer,Solid Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,516,7777,0.6811492084,0.4459218367,1.0404609191,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,718,1739,0.2070926523,0.0666744783,0.643235129,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3345,6176,0.6725760994,0.454521367,0.9952416813,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,516,7777,0.6923466051,0.4506046941,1.0637790238,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,718,1739,0.1949734879,0.0632904943,0.6006377641,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3345,6176,0.654532928,0.4420023535,0.9692558206,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,516,7777,0.6211532365,0.4073846569,0.9470934576,1,1
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,718,1739,0.1925241854,0.0614776954,0.6029107258,1,1
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3345,6176,0.667676721,0.4513269594,0.9877367049,1,1
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,516,7777,0.6752288504,0.4421525214,1.0311690612,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,718,1739,0.2033710048,0.0659621499,0.627022704,1,1
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3345,6176,0.6614349846,0.4464935757,0.9798488997,1,1
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,516,7777,0.6227461082,0.4063808695,0.9543084934,1,1
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,718,1739,0.2073403653,0.0668904894,0.6426926681,1,1
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3345,6176,0.6672180456,0.4504416219,0.9883187936,1,1
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,516,7777,0.687702083,0.4463863874,1.0594726191,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,721,1747,0.3562999801,0.1246069496,1.0188009275,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3363,6214,0.8166120806,0.4905083046,1.359518858,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,529,7899,0.5662869526,0.3758492728,0.853216797,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,721,1747,0.1812794585,0.0541489313,0.6068862534,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3363,6214,0.8577922127,0.4769998436,1.5425738398,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,529,7899,0.6859745862,0.3873222609,1.2149085669,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,721,1747,0.2023468875,0.0616104073,0.6645673141,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3363,6214,0.8675584446,0.4821522944,1.5610371734,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,529,7899,0.696003173,0.3903086313,1.2411214561,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,721,1747,0.1818573677,0.0547068508,0.6045331012,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3363,6214,0.8524737981,0.4744751901,1.531611329,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,529,7899,0.6642668473,0.3646468356,1.2100761649,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,721,1747,0.1812094865,0.0541117263,0.6068347885,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3363,6214,0.8589433079,0.4776711009,1.5445431066,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,529,7899,0.6829691885,0.3859629821,1.2085275893,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,721,1747,0.1996088878,0.0607215212,0.6561711119,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3363,6214,0.8633874505,0.4802576061,1.5521625901,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,529,7899,0.6717540658,0.3641411765,1.2392268551,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,721,1747,0.2123380627,0.0649112316,0.6946017167,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3363,6214,0.8653698194,0.4813248105,1.5558411036,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,529,7899,0.6985833279,0.3901889479,1.2507239598,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,727,1750,4.0561633E-6,2.5083542E-6,6.5590661E-6,0,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3365,6224,0.4868361001,0.2788277409,0.8500208323,1,1
Cardiac disease,Conduction Block,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,540,7936,0.5089428768,0.3211081768,0.8066529307,1,1
Cardiac disease,Conduction Block,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,727,1750,1.2132514E-6,6.7102979E-7,2.1936118E-6,0,0
Cardiac disease,Conduction Block,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3365,6224,0.6151377299,0.3111136506,1.2162578723,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,540,7936,0.5253799604,0.2880324797,0.9583089485,1,1
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,727,1750,1.0822051E-6,5.3733266E-7,2.1795954E-6,0,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3365,6224,0.6073208418,0.3070329129,1.2012998914,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,540,7936,0.5220487719,0.2861205206,0.9525179098,1,1
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,727,1750,1.2186162E-6,6.9089017E-7,2.1494377E-6,0,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3365,6224,0.605769311,0.3064348988,1.1975021761,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,540,7936,0.4917244234,0.2717144212,0.88987882,1,1
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,727,1750,3.2373902E-6,1.7887649E-6,5.8591798E-6,0,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3365,6224,0.6158204356,0.3114722196,1.2175558042,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,540,7936,0.5491112506,0.3033860608,0.9938596544,1,1
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,727,1750,1.0532663E-6,5.4776255E-7,2.0252753E-6,0,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3365,6224,0.599026201,0.3029034401,1.184642833,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,540,7936,0.5072746449,0.2810845463,0.9154810137,1,1
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,727,1750,4.22318E-7,2.0332275E-7,8.7718906E-7,0,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3365,6224,0.6012047349,0.306324287,1.1799493172,1,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,540,7936,0.5127777318,0.2783297777,0.9447102798,1,1
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,727,1750,0.0000256949,3.613652E-6,0.0001827043,0,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3375,6238,0.6488578901,0.252048518,1.6703790398,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,555,8008,0.6190754279,0.3275711754,1.1699881255,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,727,1750,9.1441358E-6,1.2449576E-6,0.0000671631,0,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3375,6238,0.6874982651,0.2510896659,1.8824106631,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,555,8008,0.5972158882,0.2693574299,1.3241395169,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,727,1750,7.6368602E-6,1.0195224E-6,0.0000572049,0,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3375,6238,0.671950158,0.2456418643,1.838111008,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,555,8008,0.6017818461,0.2685546429,1.3484830737,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,727,1750,9.2013701E-6,1.263823E-6,0.0000669914,0,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3375,6238,0.6742888611,0.2465644711,1.8440023666,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,555,8008,0.5508261123,0.2469386552,1.2286833172,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,727,1750,9.1090266E-6,1.240272E-6,0.0000669001,0,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3375,6238,0.6873754036,0.2510480768,1.8820496515,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,555,8008,0.590949229,0.2679867463,1.3031278453,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,727,1750,7.5809643E-6,1.0290325E-6,0.0000558496,0,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3375,6238,0.6579105643,0.2406868409,1.7983796243,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,555,8008,0.5556718483,0.2471243775,1.2494566749,1,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,727,1750,2.1984897E-6,2.8904145E-7,0.000016722,0,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3375,6238,0.6623464709,0.2443904235,1.7950901726,1,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,555,8008,0.6131687954,0.2746734931,1.3688105372,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,0.580832581,0.3394844706,0.9937611773,1,1
Infection,Hospitalized infection,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,1.0376686792,0.8604407169,1.2514009003,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,0.833609321,0.682649205,1.0179525516,1,0
Infection,Hospitalized infection,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,0.5202648021,0.1908868055,1.4179893868,1,0
Infection,Hospitalized infection,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,1.0066203912,0.8057177498,1.2576173384,1,0
Infection,Hospitalized infection,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,0.8857677295,0.6655853185,1.1787887276,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,0.4523191724,0.1566678096,1.3059009015,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,0.9870823354,0.7897043201,1.2337928413,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,0.8795914706,0.6644913225,1.164320931,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,0.5193226536,0.1896585664,1.422008105,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,1.0094801821,0.8077066753,1.2616588043,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,0.8955772711,0.666222067,1.2038908471,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,0.5203166387,0.1909120563,1.418084377,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,1.006293614,0.805575,1.2570236633,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,0.8727378453,0.6547938961,1.1632230403,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,0.4528301524,0.1564820986,1.3104064224,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,0.9879764822,0.7902406425,1.2351902406,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,0.8734935306,0.6542587953,1.1661913503,1,0
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,0.4706215296,0.1641836157,1.3490056429,1,0
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,0.9822839742,0.7857619269,1.2279569332,1,0
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,0.8912020971,0.6748455823,1.1769228379,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,1.6404029611,0.6709197493,4.0107954452,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,1.1028086058,0.747927109,1.6260766677,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,0.7608845385,0.4885345244,1.1850652348,1,0
Infection,Opportunistic infection,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,1.1223302049,0.3637199907,3.4631725532,1,0
Infection,Opportunistic infection,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,1.049458086,0.6428515105,1.713245215,1,0
Infection,Opportunistic infection,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,0.6180221493,0.3539183648,1.079207566,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,1.0721962757,0.340057484,3.3806191829,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,1.0254262856,0.6277066935,1.6751439458,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,0.6143678407,0.3536037642,1.0674316338,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,1.117356086,0.3535085517,3.5316956739,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,1.0691011093,0.6550325578,1.7449165974,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,0.6650085447,0.3734482742,1.1841971031,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,1.1222674036,0.3636853457,3.4631148599,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,1.0501834354,0.6432971182,1.714425911,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,0.631369488,0.3629611043,1.098264871,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,1.0801417745,0.333014951,3.5034650834,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,1.0480284354,0.6418359242,1.7112840835,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,0.6695202445,0.3812436074,1.1757767189,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,1.1425850429,0.3622780374,3.6035874258,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,1.0184462535,0.6272532667,1.6536107921,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,0.5943042135,0.3359115985,1.051459669,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,686,1731,1.2756165815,0.6189720336,2.6288710551,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3232,6155,0.9577833472,0.680384903,1.3482793874,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,531,7985,1.4087656159,0.7098098918,2.7959888747,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,686,1731,1.852162419,0.5495361234,6.2425479967,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3232,6155,0.9337893397,0.6350462805,1.3730692673,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,531,7985,2.2082106004,0.838610422,5.8146118001,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,686,1731,2.1048445785,0.6084156755,7.2818155054,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3232,6155,0.9479818137,0.64386654,1.3957388111,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,531,7985,2.2244982002,0.8407190048,5.8859050582,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,686,1731,1.8651080181,0.5547524031,6.2705954943,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3232,6155,0.9284673384,0.6291070498,1.3702780772,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,531,7985,2.1479892434,0.779287989,5.9206068295,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,686,1731,1.8516577634,0.549284109,6.2420092199,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3232,6155,0.9353618148,0.6360659775,1.3754889515,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,531,7985,2.2860294455,0.8717917822,5.9944710795,1,0
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,686,1731,2.0907480236,0.6087196965,7.1810183294,1,0
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3232,6155,0.9461080286,0.6396272686,1.3994406521,1,0
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,531,7985,2.2714454073,0.7954496385,6.4862236257,1,0
Inflammatory bowel disease,Crohn’s Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,686,1731,2.1643756297,0.6276684159,7.4633703838,1,0
Inflammatory bowel disease,Crohn’s Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3232,6155,0.9272035954,0.6323304981,1.3595841256,1,0
Inflammatory bowel disease,Crohn’s Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,531,7985,2.1936771026,0.8368590946,5.7503339108,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,712,1743,0.5857635677,0.2211230472,1.5517105139,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3296,6195,0.8430826185,0.5918575623,1.2009448671,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,537,7994,1.2357001184,0.6672951809,2.2882748539,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,712,1743,0.3880924916,0.127918661,1.1774340101,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3296,6195,0.8189265304,0.5307814991,1.2634966807,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,537,7994,1.2055924154,0.5166648182,2.8131450426,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,712,1743,0.3759412081,0.1209025771,1.168972534,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3296,6195,0.8088700089,0.5233138743,1.2502452607,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,537,7994,1.1953096698,0.5104740476,2.7988988149,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,712,1743,0.3881606256,0.1280885486,1.1762852571,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3296,6195,0.8182946346,0.5291918785,1.2653370853,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,537,7994,1.2019225159,0.5249734722,2.7517918728,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,712,1743,0.3880074812,0.1278708851,1.1773579686,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3296,6195,0.8193194503,0.5309819106,1.264232073,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,537,7994,1.2313421715,0.5255120435,2.8851927598,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,712,1743,0.374816981,0.1204687556,1.1661759806,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3296,6195,0.8097436771,0.5229628262,1.2537885863,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,537,7994,1.2145167247,0.5264685961,2.8017832125,1,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,712,1743,0.3825773862,0.1211215548,1.2084179126,1,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3296,6195,0.8156724774,0.5274357807,1.2614267266,1,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,537,7994,1.2210953569,0.5270988178,2.8288317488,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,726,1748,4.7916047414,0.436928253,52.547473964,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3376,6242,1.243695422,0.2781824064,5.5603024031,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,560,8037,1.3413235408,0.1719650979,10.462290683,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,726,1748,4.1494701362,0.3325905052,51.769675151,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3376,6242,1.0560922211,0.1978276623,5.6378909127,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,560,8037,0.283226236,0.0349748871,2.293562823,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,726,1748,5.4288239689,0.4382747231,67.245789308,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3376,6242,1.0642895399,0.1968642834,5.7537721167,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,560,8037,0.2887785093,0.0355362592,2.3467024783,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,726,1748,4.269042695,0.3441781477,52.951431263,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3376,6242,1.0275864054,0.1932628908,5.4637174074,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,560,8037,0.2511419367,0.0290236052,2.1731370721,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,726,1748,4.1514576376,0.3326406519,51.811468082,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3376,6242,1.0542550168,0.1976617838,5.6230072349,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,560,8037,0.2651933803,0.0295301256,2.3815519767,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,726,1748,5.097640799,0.4225252368,61.501513886,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3376,6242,1.031324264,0.1915046876,5.5540663313,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,560,8037,0.2502289011,0.0275282842,2.2745516066,1,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,726,1748,5.851913496,0.4768552433,71.814019136,1,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3376,6242,1.0810368676,0.2002126035,5.8369987153,1,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,560,8037,0.3037017209,0.0374200717,2.4648465698,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,4886602.571,1203823.9512,19835861.102,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3377,6242,1.7065790235,0.1036886401,28.088052469,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8044,2.2335582825,0.2718924613,18.348366767,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,541887.28639,124577.85708,2357094.8965,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3377,6242,0.8839726411,0.0550346314,14.198471217,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8044,12.191504311,1.5251575099,97.454050747,1,1
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,1938722.431,455254.34938,8256142.2418,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3377,6242,0.9095839304,0.0567217213,14.585998239,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8044,12.399289616,1.5380966026,99.956259388,1,1
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,535326.82974,118263.55784,2423187.8346,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3377,6242,0.9098678591,0.0567326709,14.592288848,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8044,13.811041124,1.5848209733,120.35735275,1,1
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,4710573.36,1082838.2177,20491982.105,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3377,6242,0.8855681512,0.0551333419,14.224259276,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8044,12.676092823,1.5892338428,101.10741725,1,1
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,7026169.2134,1694639.6843,29131298.101,0,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3377,6242,0.9472051578,0.0590722643,15.18813647,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8044,16.740191184,1.7857369226,156.92905116,1,1
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,3760605.5238,868265.6831,16287818.557,0,0
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3377,6242,0.9332153855,0.0581072402,14.987649617,1,0
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8044,12.555317875,1.5823932281,99.618732024,1,1
Lung disease,Apical Pulmonary fibrosis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,2.752756E-9,3.87433E-10,1.9558645E-8,0,0
Lung disease,Apical Pulmonary fibrosis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,1.0000029947,0.9434643196,1.0599298443,1,0
Lung disease,Apical Pulmonary fibrosis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,0.999957827,0.9109610867,1.0976491426,1,0
Lung disease,Apical Pulmonary fibrosis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,9.446012E-13,1.290662E-13,6.913285E-12,0,0
Lung disease,Apical Pulmonary fibrosis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,1,0.9326841349,1.0721743434,1,0
Lung disease,Apical Pulmonary fibrosis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,1,0.8608291171,1.161670743,1,0
Lung disease,Apical Pulmonary fibrosis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,1,1,1,1,0
Lung disease,Apical Pulmonary fibrosis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,1,1,1,1,0
Lung disease,Apical Pulmonary fibrosis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,1,1,1,1,0
Lung disease,Apical Pulmonary fibrosis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,8.183857E-17,6.422999E-17,1.042745E-16,0,0
Lung disease,Apical Pulmonary fibrosis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,1,1,1,1,0
Lung disease,Apical Pulmonary fibrosis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,1,1,1,1,0
Lung disease,Apical Pulmonary fibrosis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,9.446012E-13,1.29058E-13,6.913725E-12,0,0
Lung disease,Apical Pulmonary fibrosis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,1,0.9326961824,1.0721604943,1,0
Lung disease,Apical Pulmonary fibrosis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,1,0.8676376226,1.1525549076,1,0
Lung disease,Apical Pulmonary fibrosis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,1,1,1,1,0
Lung disease,Apical Pulmonary fibrosis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,1,1,1,1,0
Lung disease,Apical Pulmonary fibrosis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,1,1,1,1,0
Lung disease,Apical Pulmonary fibrosis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,9.419761E-20,5.051404E-20,1.756579E-19,0,0
Lung disease,Apical Pulmonary fibrosis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3378,6242,1,1,1,1,0
Lung disease,Apical Pulmonary fibrosis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,561,8045,1,1,1,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,0.9872955285,0.8964702648,1.0873226908,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3377,6242,0.4173780522,0.0466143281,3.7371436083,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,555,8025,1.0924957595,0.3354798082,3.5577312112,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,1.0094163886,0.6794370852,1.4996553292,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3377,6242,1.1065557721,0.1232976548,9.9309729641,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,555,8025,1.2737991151,0.2983400408,5.438640356,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,0.7544577952,0.4913397701,1.15847851,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3377,6242,1.0585392096,0.115984888,9.6607866569,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,555,8025,1.2895104926,0.2966677101,5.6050498713,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,0.9874590355,0.6050209495,1.6116389816,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3377,6242,1.1291605404,0.1253950189,10.167896116,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,555,8025,1.3807524079,0.2989816809,6.3765686455,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,1.0095054578,0.679464316,1.4998598828,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3377,6242,1.1068520358,0.1233269539,9.9339308248,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,555,8025,1.2834878376,0.29490195,5.5860635349,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,0.7451713892,0.4507063386,1.2320226091,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3377,6242,1.0826585873,0.1181510762,9.9207696978,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,555,8025,1.3710631985,0.3009510265,6.2462464938,1,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1750,0.8040021888,0.5509185822,1.1733485502,1,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3377,6242,1.0691605411,0.1142497571,10.005310227,1,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,555,8025,1.3300914468,0.3160766206,5.5971974559,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,722,1748,0.142927846,0.0190524715,1.0722162308,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3360,6224,0.7632439434,0.4560457365,1.2773747686,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,537,7957,0.6085555283,0.3487847533,1.061800516,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,722,1748,1.416750231,0.1895764359,10.587714698,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3360,6224,0.7979634956,0.464101692,1.3719961624,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,537,7957,0.3503170855,0.1854387841,0.6617928446,1,1
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,722,1748,1.3729268005,0.1666384889,11.31148039,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3360,6224,0.7950882112,0.4622891807,1.3674671397,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,537,7957,0.3497208718,0.1853207263,0.6599622753,1,1
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,722,1748,1.4214754589,0.1929302284,10.473177259,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3360,6224,0.7899063107,0.4589953805,1.359386186,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,537,7957,0.3325038735,0.176613695,0.625992372,1,1
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,722,1748,1.4165581852,0.1895421051,10.586761665,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3360,6224,0.798197724,0.4642349199,1.3724077599,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,537,7957,0.3505115378,0.1855278801,0.6622095723,1,1
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,722,1748,1.3661608637,0.1699982754,10.978908471,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3360,6224,0.7862717184,0.4567748529,1.3534528252,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,537,7957,0.3318059321,0.1765494634,0.623593946,1,1
Lung disease,Restrictive lung disease ,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,722,1748,1.4615642859,0.1860482637,11.481806489,1,0
Lung disease,Restrictive lung disease ,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3360,6224,0.7794357229,0.4531761268,1.3405826347,1,0
Lung disease,Restrictive lung disease ,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,537,7957,0.3345134281,0.1754535168,0.6377713917,1,1
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1749,2.5076814E-6,5.7643617E-7,0.0000109092,0,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3375,6236,2.0952146621,0.5645080605,7.776548799,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,560,8040,0.4830641822,0.0652833333,3.5744345821,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1749,7.9822512E-7,1.9048427E-7,3.3449657E-6,0,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3375,6236,3.6833027923,0.6697192059,20.257324773,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,560,8040,0.2346404754,0.0298933438,1.8417529015,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1749,1.5486888E-6,3.607277E-7,6.6488851E-6,0,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3375,6236,3.6856809255,0.6606803904,20.560991489,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,560,8040,0.2360520432,0.0298073239,1.8693582548,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1749,8.0448986E-7,1.9500512E-7,3.3189073E-6,0,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3375,6236,3.638034902,0.6719750373,19.696115501,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,560,8040,0.2223029391,0.0264437028,1.8688228745,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1749,1.8123928E-6,4.3315036E-7,7.5834352E-6,0,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3375,6236,3.6661619625,0.6662575194,20.1734962,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,560,8040,0.2145035843,0.0304989651,1.5086343904,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1749,1.4627279E-6,3.4647575E-7,6.1752462E-6,0,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3375,6236,3.628448129,0.6581545028,20.003868042,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,560,8040,0.2145809537,0.0254985073,1.8057914188,1,0
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,728,1749,7.4851169E-7,1.807164E-7,3.1002706E-6,0,0
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3375,6236,3.8284620215,0.6768120317,21.656118338,1,0
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,560,8040,0.250962304,0.0318322171,1.9785639733,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,724,1749,0.4493719309,0.1727302212,1.1690781779,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3371,6235,0.4918369568,0.2708870183,0.893005481,1,1
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,545,7929,0.6313576781,0.401437214,0.9929635414,1,1
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,724,1749,0.3143550155,0.0952341429,1.0376433576,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3371,6235,0.7958276866,0.3691279896,1.7157780621,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,545,7929,0.6576583727,0.3596581227,1.2025712975,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,724,1749,0.3036445556,0.0892107681,1.0335077041,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3371,6235,0.7928493191,0.3683840109,1.7063988235,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,545,7929,0.6565894061,0.3588033006,1.2015208541,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,724,1749,0.312530599,0.0934788224,1.0448930876,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3371,6235,0.8042017655,0.3722701417,1.7372880797,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,545,7929,0.685040656,0.3727810163,1.2588642657,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,724,1749,0.3143577713,0.0952353714,1.0376481644,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3371,6235,0.7957979047,0.3691066421,1.7157488728,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,545,7929,0.6568779881,0.3601921342,1.1979403499,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,724,1749,0.3023565348,0.0872808705,1.0474170758,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3371,6235,0.8013880689,0.3715549422,1.7284734074,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,545,7929,0.6849720476,0.3729895345,1.2579085001,1,0
Osteoporotic fracture,Clinical vertebral fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,724,1749,0.310608469,0.092136277,1.0471187256,1,0
Osteoporotic fracture,Clinical vertebral fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3371,6235,0.7854210669,0.3697227903,1.668510215,1,0
Osteoporotic fracture,Clinical vertebral fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,545,7929,0.673177642,0.3711849049,1.2208689838,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,722,1741,0.5774955918,0.2789004077,1.1957714988,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3353,6216,0.8978784989,0.5984681197,1.3470822793,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,537,7881,0.7044562492,0.4860843044,1.0209311484,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,722,1741,0.350980491,0.1493066271,0.8250625401,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3353,6216,1.1441628756,0.6873966022,1.9044445109,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,537,7881,0.6656125888,0.4130814674,1.0725248004,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,722,1741,0.3375641384,0.143376572,0.7947570929,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3353,6216,1.123407935,0.6750453261,1.8695713304,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,537,7881,0.6609038953,0.4119395434,1.0603351046,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,722,1741,0.3499835532,0.1476789334,0.8294242429,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3353,6216,1.149811719,0.6905007876,1.9146495021,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,537,7881,0.6782883653,0.4168158642,1.1037850187,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,722,1741,0.3509394821,0.1492775324,0.8250305194,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3353,6216,1.1446124295,0.6876750631,1.905169584,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,537,7881,0.6765433152,0.4232760638,1.0813530375,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,722,1741,0.3376838892,0.1424079456,0.800730665,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3353,6216,1.1311853702,0.6795878836,1.8828769208,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,537,7881,0.6815290101,0.426199307,1.089822963,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,722,1741,0.339821811,0.1438481723,0.8027829719,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3353,6216,1.1058796238,0.6662767374,1.8355282027,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,537,7881,0.6759340786,0.4240522698,1.0774305697,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,708,1735,1.6105236656,0.8740818577,2.9674411548,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3259,6152,1.7948503498,1.3297218766,2.4226778809,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,529,7930,1.3327230056,0.8207436251,2.1640748163,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,708,1735,0.8211075789,0.3640854645,1.851811516,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3259,6152,1.7246443768,1.2091218243,2.4599657097,1,1
PsO/PsA,Psoriasis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,529,7930,0.812135617,0.4237471192,1.5565044115,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,708,1735,0.9249894696,0.4212847721,2.0309433799,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3259,6152,1.7444701862,1.2210355744,2.4922912111,1,1
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,529,7930,0.8231673761,0.4284790089,1.5814182608,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,708,1735,0.821507901,0.3648558301,1.8497038436,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3259,6152,1.723238389,1.2056926642,2.4629415384,1,1
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,529,7930,0.8094709264,0.4321801846,1.5161342515,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,708,1735,0.8209045875,0.3639671735,1.8514975822,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3259,6152,1.7253307959,1.20958183,2.4609879888,1,1
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,529,7930,0.8303740153,0.4353260643,1.5839184966,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,708,1735,0.9242494047,0.4201433015,2.0332038117,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3259,6152,1.7467072604,1.2198755496,2.5010635344,1,1
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,529,7930,0.8450478154,0.4538486789,1.5734447263,1,0
PsO/PsA,Psoriasis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,708,1735,0.9148443433,0.4136700704,2.0232069768,1,0
PsO/PsA,Psoriasis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3259,6152,1.7307215739,1.2094151313,2.4767320078,1,1
PsO/PsA,Psoriasis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,529,7930,0.8232327163,0.4323896384,1.5673643516,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,686,1712,1.7085749139,0.9547684404,3.0575248542,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3160,6088,1.7062161215,1.295687311,2.2468179078,1,1
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,508,7911,2.7965382593,1.6936648222,4.6175761187,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,686,1712,0.7386272785,0.3365032153,1.6212928488,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3160,6088,1.7407011908,1.263423383,2.3982781042,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,508,7911,2.8496743971,1.6140254746,5.0312986364,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,686,1712,0.7298495301,0.3251630111,1.6381947464,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3160,6088,1.7410934446,1.2611787464,2.4036294548,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,508,7911,2.8482482188,1.6101369214,5.0384025158,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,686,1712,0.7393474226,0.3382941217,1.6158560739,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3160,6088,1.7367129034,1.2586383045,2.3963768607,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,508,7911,2.8207760501,1.6147414718,4.9275860339,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,686,1712,0.7383547294,0.3363446905,1.620860153,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3160,6088,1.7410301124,1.2636504176,2.3987534924,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,508,7911,2.9199254604,1.6583759674,5.1411530687,1,1
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,686,1712,0.7252951371,0.3228948427,1.6291775721,1,0
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3160,6088,1.7383014942,1.2573378766,2.4032458904,1,1
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,508,7911,2.8988402098,1.6610460391,5.0590256767,1,1
PsO/PsA,Psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,686,1712,0.7441520208,0.3373532678,1.6414906358,1,0
PsO/PsA,Psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3160,6088,1.7222104167,1.2451024272,2.3821403399,1,1
PsO/PsA,Psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,508,7911,2.8318489881,1.6058754283,4.9937676049,1,1
Uveitis,Uveitis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,686,1709,0.9392205751,0.5553686021,1.5883780346,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3188,6094,1.0627320148,0.8362774272,1.3505079756,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,534,7981,2.158914287,1.281288474,3.6376748821,1,1
Uveitis,Uveitis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,686,1709,0.4091821463,0.1942241018,0.8620455816,1,1
Uveitis,Uveitis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,3188,6094,0.9664072393,0.7326336138,1.2747749142,1,0
Uveitis,Uveitis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,534,7981,2.0281633332,0.9832521381,4.183511377,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,686,1709,0.4037156078,0.191491932,0.8511392112,1,1
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3188,6094,0.9592117274,0.725778643,1.267724184,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,534,7981,2.0418529074,0.9874171874,4.2222915994,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,686,1709,0.4145835421,0.2028986588,0.8471200075,1,1
Uveitis,Uveitis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3188,6094,0.9496194932,0.7193159983,1.2536592875,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,534,7981,1.8946214791,0.9367889981,3.8318026325,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,686,1709,0.4092058296,0.1942057967,0.8622266368,1,1
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3188,6094,0.9676959279,0.7336000916,1.276493037,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,534,7981,2.1220386128,1.0362621011,4.3454719318,1,1
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,686,1709,0.4016265407,0.1939371134,0.831732902,1,1
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3188,6094,0.9417354896,0.7118175917,1.245917132,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,534,7981,1.9668955752,0.9779938961,3.9557283735,1,0
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,686,1709,0.4161484698,0.197873421,0.8752036938,1,1
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,3188,6094,0.961770776,0.7280680406,1.2704898086,1,0
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,534,7981,2.0220290744,0.9797476608,4.173116958,1,0
